Questcor Pharmaceuticals
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Questcor Pharmaceuticals's revenues will expand 113.6% and EPS will expand 108.6%.
The average estimate for revenue is $127.8 million. On the bottom line, the average EPS estimate is $0.73.
Revenue details
Last quarter, Questcor Pharmaceuticals chalked up revenue of $112.5 million. GAAP reported sales were much higher than the prior-year quarter's $46.0 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS details
Last quarter, EPS came in at $0.65. GAAP EPS of $0.65 for Q2 were 210% higher than the prior-year quarter's $0.21 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
Recent performance
For the preceding quarter, gross margin was 94.3%, 50 basis points better than the prior-year quarter. Operating margin was 54.3%, 990 basis points better than the prior-year quarter. Net margin was 36.9%, 670 basis points better than the prior-year quarter.
Looking ahead
The full year's average estimate for revenue is $470.4 million. The average EPS estimate is $2.73.
Investor sentiment
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 459 members out of 515 rating the stock outperform, and 56 members rating it underperform. Among 124 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 99 give Questcor Pharmaceuticals a green thumbs-up, and 25 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Questcor Pharmaceuticals is outperform, with an average price target of $56.78.
Can your portfolio provide you with enough income to last through retirement? You'll need more than Questcor Pharmaceuticals. Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks." Click here for instant access to this free report.
- Add Questcor Pharmaceuticals to My Watchlist.